Impact of frontline treatment approach on outcomes in patients with secondary AML with prior hypomethylating agent exposure
暂无分享，去创建一个
M. Konopleva | G. Garcia-Manero | E. Shpall | T. Kadia | F. Ravandi | G. Borthakur | E. Jabbour | N. Daver | C. Dinardo | U. Popat | N. Short | R. Champlin | W. Qiao | R. Mehta | B. Oran | A. Maiti | G. Montalban-Bravo | H. Kantarjian | S. Venugopal | G. Issa | M. Yilmaz | G. Al-Atrash | W. Macaron